The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention.
Jiesuck ParkJung-Kyu HanJeehoon KangSi-Hyuck KangSung Yun LeeYoung Jin ChoiJay Young RhewSeung Woon RhaEun-Seok ShinSeong Ill WooHan Cheol LeeKook-Jin ChunDoo Il KimJin Ok JeongJang-Whan BaeHan Mo YangKyung Woo ParkHyun-Jae KangBon-Kwon KooHyo-Soo KimPublished in: Korean circulation journal (2022)
ClinicalTrials.gov Identifier: NCT03507205.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- cardiovascular events
- angiotensin converting enzyme
- stem cells
- atrial fibrillation
- cardiovascular disease
- heart failure
- mesenchymal stem cells
- bone marrow
- cell therapy
- smoking cessation
- left ventricular